Michor F - Search Results

1

Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance.

Irurzun-Arana I, McDonald TO, Trocóniz IF, Michor F. Irurzun-Arana I, et al. Among authors: michor f. Cancer Res. 2020 Aug 15;80(16):3372-3382. doi: 10.1158/0008-5472.CAN-20-0056. Epub 2020 Jun 19. Cancer Res. 2020. PMID: 32561532 Free PMC article.

2

Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer.

Foo J, Chmielecki J, Pao W, Michor F. Foo J, et al. Among authors: michor f. J Thorac Oncol. 2012 Oct;7(10):1583-93. doi: 10.1097/JTO.0b013e31826146ee. J Thorac Oncol. 2012. PMID: 22982659 Free PMC article.

3

Genetic and phenotypic diversity in breast tumor metastases.

Almendro V, Kim HJ, Cheng YK, Gönen M, Itzkovitz S, Argani P, van Oudenaarden A, Sukumar S, Michor F, Polyak K. Almendro V, et al. Among authors: michor f. Cancer Res. 2014 Mar 1;74(5):1338-48. doi: 10.1158/0008-5472.CAN-13-2357-T. Epub 2014 Jan 21. Cancer Res. 2014. PMID: 24448237 Free PMC article.

4

Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients.

Liu LL, Li F, Pao W, Michor F. Liu LL, et al. Among authors: michor f. PLoS One. 2015 Nov 4;10(11):e0141665. doi: 10.1371/journal.pone.0141665. eCollection 2015. PLoS One. 2015. PMID: 26536620 Free PMC article.

5

Punctuated copy number evolution and clonal stasis in triple-negative breast cancer.

Gao R, Davis A, McDonald TO, Sei E, Shi X, Wang Y, Tsai PC, Casasent A, Waters J, Zhang H, Meric-Bernstam F, Michor F, Navin NE. Gao R, et al. Among authors: michor f. Nat Genet. 2016 Oct;48(10):1119-30. doi: 10.1038/ng.3641. Epub 2016 Aug 15. Nat Genet. 2016. PMID: 27526321 Free PMC article.

6

SIApopr: a computational method to simulate evolutionary branching trees for analysis of tumor clonal evolution.

McDonald TO, Michor F. McDonald TO, et al. Among authors: michor f. Bioinformatics. 2017 Jul 15;33(14):2221-2223. doi: 10.1093/bioinformatics/btx146. Bioinformatics. 2017. PMID: 28334409 Free PMC article.

7

Mathematical Modeling Links Pregnancy-Associated Changes and Breast Cancer Risk.

Temko D, Cheng YK, Polyak K, Michor F. Temko D, et al. Among authors: michor f. Cancer Res. 2017 Jun 1;77(11):2800-2809. doi: 10.1158/0008-5472.CAN-16-2504. Epub 2017 Mar 30. Cancer Res. 2017. PMID: 28360138 Free PMC article.

8

Pharmacokinetics and Drug Interactions Determine Optimum Combination Strategies in Computational Models of Cancer Evolution.

Chakrabarti S, Michor F. Chakrabarti S, et al. Among authors: michor f. Cancer Res. 2017 Jul 15;77(14):3908-3921. doi: 10.1158/0008-5472.CAN-16-2871. Epub 2017 May 31. Cancer Res. 2017. PMID: 28566331 Free PMC article.

9

Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients.

Stein S, Zhao R, Haeno H, Vivanco I, Michor F. Stein S, et al. Among authors: michor f. PLoS Comput Biol. 2018 Jan 2;14(1):e1005924. doi: 10.1371/journal.pcbi.1005924. eCollection 2018 Jan. PLoS Comput Biol. 2018. PMID: 29293494 Free PMC article.

10

Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution.

McDonald TO, Chakrabarti S, Michor F. McDonald TO, et al. Among authors: michor f. Nat Genet. 2018 Dec;50(12):1620-1623. doi: 10.1038/s41588-018-0217-6. Nat Genet. 2018. PMID: 30374067 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters